Skip to main content

Cancer Gene Therapy Market, 2032 - ResearchAndMarkets.com

The "Cancer Gene Therapy Market" report has been added to ResearchAndMarkets.com's offering.

A recent market study published on Cancer Gene Therapy offers a global industry analysis for 2017-2021 and opportunity assessment for 2022-2032.

The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Companies Mentioned

  • Merck KGaA
  • Novartis AG
  • AstraZeneca Plc.
  • BIOCAD
  • Crinetics Pharmaceuticals, Inc.
  • EffRx Pharmaceuticals S.A.
  • Euroscreen S.A.
  • Vicore Pharma AB
  • Amgen
  • Bristol-Myers Squibb
  • Cell Genesys Inc.
  • Adaptimmune Therapeutics plc.
  • Achieve Life Science Inc.
  • BioCanCell Ltd.
  • Genelux Corporation
  • Advantagene Inc.
  • GenVec Inc.
  • GlaxoSmithKline PLC
  • Amgen Inc.

Key Topics Covered:

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Technology Roadmap

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage/Taxonomy

2.2. Market Definition/Scope/Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation/Development Trends

4. Key Success Factors

4.1. Technology Assessment

4.2. Disease Epidemiology

4.3. Regulatory Landscape

4.4. Reimbursement Outlook

4.5. Key Marketing & Promotional Strategies Adopted By Companies

4.6. PESTLE Analysis

4.7. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Rise in Healthcare Spending

5.1.3. Global Expenditure on Healthcare Infrastructure

5.2. Forecast Factors - Relevance & Impact

5.2.1. Mergers and Acquisitions

5.2.2. Disease Prevalence and Growth

5.2.3. R&D for Cancer Gene Therapy

5.2.4. Technological Advancements

5.2.5. Regulatory Framework

5.2.6. Reimbursement Policies

5.2.7. Prevalence of Geriatric Age Group

5.2.8. Global Burden of Cancer

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis

6.1.1. Revenue By Therapy

6.1.2. Revenue By Indication

6.1.3. Revenue By Service Provider

6.1.4. Revenue By Country

6.2. 2021 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2017-2021 and Forecast, 2022-2032

7.1. Historical Market Value (US$ Bn) Analysis, 2017-2021

7.2. Current and Future Market Value (US$ Bn) Projections, 2022-2032

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Therapy

8.1. Introduction/Key Findings

8.2. Historical Market Size (US$ Bn) Trend Analysis, By Therapy, 2017-2021

8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Therapy, 2022-2032

8.3.1. Gene Induced Immunotherapy

8.3.2. Oncolytic Virotherapy

8.3.3. Gene Transfer

8.3.4. Others

8.4. Market Attractiveness Analysis By Therapy

9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Indication

9.1. Introduction/Key Findings

9.2. Historical Market Size (US$ Bn) Trend Analysis, By Indication, 2017-2021

9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Indication, 2022-2032

9.3.1. Breast Cancer

9.3.2. Ovarian Cancer

9.3.3. Liver Cancer

9.3.4. Pancreatic Cancer

9.3.5. Lung Cancer

9.3.6. Prostate Cancer

9.4. Market Attractiveness Analysis By Indication

10. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Service Provider

10.1. Introduction/Key Findings

10.2. Historical Market Size (US$ Bn) Trend Analysis, By Service Provider, 2017-2021

10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Service Provider, 2022-2032

10.3.1. Hospitals

10.3.2. Clinical Research Laboratory

10.3.3. Oncology institutes

10.4. Market Attractiveness Analysis By Service Provider

For more information about this report visit https://www.researchandmarkets.com/r/oxhr03-gene?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.